Drug Discovery World

OCTOBER 16, 2023

This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture. billion in funding. Northern Ireland “Northern Ireland is a medtech super-hub,” says Saleko.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

The Pharma Data

APRIL 17, 2021

TECFIDERA was approved under the National Medical Products Administration priority review process evaluating therapies with urgent clinical needs. Biogen’s expansion in China now includes treatment options approved for relapsing MS and spinal muscular atrophy.

Treatment 52

Treatment Clinical Trials Disease Trials 52

The Pharma Data

MARCH 17, 2022

Merck (NYSE: MRK), known as MSD outside the United States and Canada, the European Organisation for Research and Treatment of Cancer (EORTC) and the European Thoracic Oncology Platform (ETOP) today announced results from the pivotal Phase 3 KEYNOTE-091 trial, also known as EORTC-1416-LCG/ETOP-8-15 – PEARLS. About EORTC. About ETOP.

Therapies 52

Therapies Clinical Trials Disease Trials 52

Olympian Clinical Research

OCTOBER 14, 2021

We’ve outlined five reasons why joining a clinical trial might be in your best interest. The whole point of clinical trials is to gather information about new treatments and drugs. When you join a clinical trial, you’ll be assigned to a team of doctors and researchers who will monitor your health very closely.

Clinical Trials 52

Clinical Trials Trials Doctors Therapies 52

Drug Discovery World

JANUARY 26, 2024

In the first case of its kind, gene therapy has restored hearing in a patient in the United States. AK-OTOF is a gene therapy being developed for the treatment of sensorineural hearing loss due to mutations in the otoferlin gene (OTOF).

Therapies 260

Therapies Clinical Trials Hospitals Trials 260

Drug Discovery World

SEPTEMBER 28, 2022

Yet despite this, the biggest players in the global pharma sector are increasingly opening their doors to partnerships with AI and machine learning companies, cognisant of the potential benefits these could provide across broad therapy areas such as oncology, autoimmune and rare diseases. . How AI can streamline drug discovery .

Pharma Companies 130

Pharma Companies Hospitals Clinical Trials Drugs 130

Precision for Medicine

JUNE 26, 2023

This acquisition allows us to vastly expand our capabilities and deliver efficient and strategic solutions that drive the path forward for manufacturing complex treatments while ensuring reliable and consistent drug supply chains.” Bethesda, Md., For more information, visit projectfarma.com.

Science 40

Science Small Molecule Clinical Research Engineering 40

The Pharma Data

JUNE 26, 2021

The Phase 3 AMEERA-6 study will evaluate the efficacy and safety of Sanofi’s amcenestrant vs tamoxifen for women with estrogen receptor-positive (ER+) breast cancer who were unable to continue their adjuvant aromatase inhibitor (AI) therapy. Adjuvant therapy helps prevent and delay the progression of disease into the later setting.

Clinical Trials 52

Clinical Trials International Trials Therapies 52

The Pharma Data

AUGUST 15, 2021

WELIREG Approved for Adult Patients With VHL Disease Who Require Therapy for Associated Renal Cell Carcinoma, Central Nervous System Hemangioblastomas, or Pancreatic Neuroendocrine Tumors, Not Requiring Immediate Surgery. inhibitor therapy approved in the U.S. WELIREG is the first HIF-2? As an inhibitor of HIF-2?,

Treatment 52

Treatment Disease Clinical Trials Therapies 52

NIH Director's Blog: Drug Development

FEBRUARY 16, 2021

hospitals are stretched to the limit trying to help people battling serious cases of COVID-19. This improvement stems from several factors, including the FDA’s emergency use authorization (EUA) of a number of therapies found to be safe and effective for COVID-19. Credit: NIH Right now, many U.S.

Clinical Trials 52

Clinical Trials Hospitals Vaccine Trials 52

Drug Discovery World

OCTOBER 20, 2022

This is unsurprising – our drug discovery industry does, after all, centre itself around creating initiatives that leave no one behind, from cancer therapies to malaria vaccines. . To this end, pharmaceutical company ViiV Healthcare received approval in Japan for its long-acting HIV treatment in May 2022 5. Overview .

Drugs 130

Drugs International Science Government 130

Agency IQ

NOVEMBER 3, 2023

regulatory landscape for probiotics and other microbiome-based therapies Probiotics, a type of microbiome-based therapy containing live micro-organisms, are broadly available on drug store and grocery store shelves, but the regulatory classifications for products containing the same micro-organism can differ dramatically.

Therapies 40

Therapies Science FDA Production 40

The Pharma Data

AUGUST 30, 2021

There is currently a lack of therapies for ARDS associated with COVID-19. Given the central role played by neutrophils in ARDS, the team postulated that metoprolol might be an effective treatment for patients with severe COVID-19. The study is a prime example of collaboration between basic and clinical researchers.

Clinical Trials 52

Clinical Trials Drugs Trials Hospitals 52

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. Starpharma strived to release DEP remdesivir to allow for less frequent dosing and for use in non-hospital settings such as care homes. Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Pharma Companies Hospitals Trials 52

The Pharma Data

MARCH 23, 2023

Dupixent is the first and only biologic to demonstrate a clinically meaningful and highly significant reduction (30%) in moderate or severe acute exacerbations of COPD (rapid and acute worsening of respiratory symptoms), while also demonstrating significant improvements in lung function, quality of life and COPD respiratory symptoms.

Trials 40

Trials Disease Treatment Therapies 40

The Pharma Data

NOVEMBER 8, 2020

First randomized clinical trial demonstrating that CTC count may help personalize treatment choices. “Furthermore, our results indicate that the CTC count complements but does not duplicate the physician’s opinion on which treatment to choose and should be included in the decision algorithm. .

Research 40

Research Clinical Trials Therapies Treatment 40

The Pharma Data

OCTOBER 22, 2020

It is the first antiviral treatment proven to help patients hospitalized with COVID-19 recover more quickly – a significant benefit for patients and their families, for healthcare providers and hospitals, and for society at large.

Science 52

Science Clinical Trials Hospitals FDA Approval 52

The Pharma Data

SEPTEMBER 28, 2020

Developing next-generation therapies. This leaves patients tired and short of breath, and at risk of hospitalization or sudden cardiac death. Assessing an innovative therapy for patients with Chagas cardiomyopathy. Novartis started helping people with CVDs over 60 years ago. Follow us on social media: #NovartisGlobalHealth.

Disease 52

Disease Therapies Treatment Government 52

The Pharma Data

SEPTEMBER 7, 2021

First Anti-PD-1 Regimen Approved in China for First-Line Treatment of Advanced Esophageal or GEJ Cancer, Regardless of Histology or PD-L1 Expression. Shen Lin, vice president, Clinical Oncology, Beijing Cancer Hospital and Peking University, and deputy director, Beijing Institute for Cancer Research. 0.86]; p<0.0001).

Treatment 52

Treatment Research Laboratories Packaging Laboratories 52

The Pharma Data

DECEMBER 16, 2020

The decision makes Benlysta the first lupus therapy authorized to treat this potentially life-threatening complication of the disease. Effective treatment can greatly improve health outcomes and reduce the long-term costs associated with managing lupus-related kidney disease.” ” Dr. Susan M.

FDA Approval 52

FDA Approval FDA Clinical Trials Treatment 52

The Pharma Data

SEPTEMBER 1, 2020

The trial included 2,494 patients who had previously completed a Phase 1, 2 or 3 Zeposia clinical trial and who had an average treatment time of 35.4 Gaining insight into long-term therapeutic outcomes can enable clinicians to identify the most appropriate treatment approach for their multiple sclerosis patients. Author: Harris.

Clinical Trials 52

Clinical Trials Treatment Trials Disease 52

Drug Discovery World

FEBRUARY 26, 2024

Reece Armstrong speaks to Kathryn Golden , SVP Technical Operations and Manufacturing, bit.bio, about novel technologies, and methods to manufacture human cells for therapies so more patients can access these treatments. Cell therapies have emerged as transformative and potentially curative treatments across a range of disease areas.

Therapies 130

Therapies Treatment Engineering Disease 130

The Pharma Data

JANUARY 12, 2021

We are all aware that the process between patient identification and enrollment is significantly inefficient and ineffective, especially for those patients that are currently not getting treatment in research-oriented sites.

Clinical Trials 52

Clinical Trials Trials Clinical Research Pharmaceutical Companies 52

The Pharma Data

JULY 29, 2021

Our flagship HIV therapy, Biktarvy, saw continued growth and gains in market share, despite the ongoing impact of the pandemic,” said Daniel O’Day, Chairman and Chief Executive Officer, Gilead Sciences. Cell Therapy product sales increased 39% to $219 million for the second quarter 2021 compared to the same period in 2020.

Science 52

Science Production Treatment FDA 52

The Pharma Data

NOVEMBER 10, 2020

We believe the scientific rationale for oral treatment with Foralumab is logical to facilitate topical action at the inflamed sites in the gastrointestinal tract. This potentially ground-breaking approach for immunotherapies originated in my laboratory and was subsequently reported by other researchers in the field.”.

Clinical Trials 40

Clinical Trials Science Disease Trials 40

The Pharma Data

NOVEMBER 1, 2020

In view of the importance and urgency, scientific teams at the Harvard Medical School, Santa Casa de Misericórdia de Santos Hospital (Jabaquara, Santos, Brazil) and at Tiziana are closely collaborating to facilitate initiation of this study in expedited time frames. Dr Howard Weiner, who is the Robert L.

Clinical Trials 52

Clinical Trials Trials Medical Schools Hospitals 52

The Pharma Data

JANUARY 17, 2021

The service is expected to become operational in 2021 and will be available for clinical research and clinical care — starting with private patients, followed by expansion into the public healthcare system over time. “We This press release features multimedia. View the full release here: [link]. About Guardant Health.

Clinical Trials 40

Clinical Trials FDA Approval Pharmaceutical Companies Treatment 40

The Pharma Data

DECEMBER 17, 2020

Most recently, Cadavid served as senior vice president and Head of Clinical Development at Fulcrum Therapeutics where he led the development of multiple small molecules for the treatment of genetically defined rare diseases. Goater is CEO at Surface Oncology, an immuno-oncology company developing next-generation antibody therapies.

Small Molecule 52

Small Molecule Engineering Pharmaceuticals Clinical Development 52

The Pharma Data

MAY 6, 2021

Glooko is transforming digital health by connecting people with diabetes and related conditions and their health care professionals, enabling telehealth, clinical research, and improved collaboration. Data is easily uploaded – remotely via app or in-clinic, securely shared, and visualized in actionable charts and graphs.

International 52

International Therapies Disease Production 52

The Pharma Data

JUNE 28, 2021

. “Plaque psoriasis is a chronic autoimmune disease in which the immune system overproduces inflammatory proteins which results in red, scaly and thickened areas of skin,” said Dr. Jennifer Soung, dermatologist and Director of Clinical Research at Southern California Dermatology in Santa Ana, California.

Clinical Trials 52

Clinical Trials Treatment Trials Disease 52

NIH Director's Blog: Drug Development

JULY 20, 2017

The first genetic mutation that causes CF was discovered by a collaborative effort between my own research lab at the University of Michigan, Ann Arbor, and colleagues at the Hospital for Sick Children in Toronto—more than 25 years ago [1]. About 30,000 Americans have CF.

Clinical Trials 52

Clinical Trials Small Molecule Disease Therapies 52

Agency IQ

MARCH 1, 2024

The EMA has a number of scientific guidelines and reflection papers that are currently open for public consultation, including the development of products for the treatment of depression, Hepatitis B, and hemophilia A and B. These include several training sessions at both the national and E.U.

Regulations 40

Regulations Biosimilars Clinical Trials Production 40

Drug Discovery World

APRIL 11, 2024

The Program Committee Chairs commented: “It has been an educational, enlightening, and inspiring week of captivating cancer science and research. And thanks to the city of San Diego for its hospitality.” Research highlights Blacksmith Medicines announced preclinical data on its oncology programme targeting flap endonuclease 1 (FEN1).

Biochemical Assays 130

Biochemical Assays DNA Science Pharmacokinetics 130

The Pharma Data

DECEMBER 15, 2020

It is funded by the world’s leading charities dedicated to diabetes research, JDRF, and Diabetes UK, guided by both organizations’ strong commitment to facilitate deep interrogation of consolidated community-wide trial data as a means to accelerate clinical research and therapeutic development for T1D.

Drug Development 40

Drug Development Clinical Trials Vaccine Trials 40

Drug Discovery World

JULY 1, 2024

million) to the academy. On the other hand, the Novo Nordisk Foundation Center for Basic Metabolic Research aims to deliver world-class research in tackling some of today’s biggest health challenges. billion DKK ($11.97 Following its inception, the Novo Nordisk Foundation awarded a grant of DKK 150 million ($21.46

Disease 162

Disease International Research Science 162

The Pharma Data

JANUARY 13, 2021

patients hospitalized with COVID-19. We are pleased vaccines are now approved for the prevention of COVID-19; however, a significant unmet need remains for effective treatments for symptomatic patients. Patient Population: 45 hospitalized patients with COVID-19. LONDON and RALEIGH, N.C., David Zaccardelli, Pharm.

Hospitals 52

Hospitals Clinical Trials Therapies Treatment 52

The Pharma Data

MAY 27, 2022

In the pivotal clinical study CARTITUDE-1, 98 percent of patients with relapsed or refractory multiple myeloma responded to a one-time treatment with ciltacabtagene autoleucel and 80 percent of patients who responded experienced a stringent complete response . Consultant Physician in Haematology, University Hospital of Salamanca.* “The

Therapies 52

Therapies Treatment Pharmaceutical Companies Nurses 52